MORAXELLA BOVOCULI BACTERIN
Look to stop pinkeye before it starts. Boost immunity against Moraxella bovoculi with a new pinkeye vaccine now available from Merck Animal Health.
Pinkeye vaccines are a critical part of a three-step approach to managing pinkeye, including fly control and pasture management.
An Effective Approach at Preventing Pinkeye
The major cause of pinkeye is due to a bacteria called M. bovis. Vaccines such as BOVILIS® PILIGUARD® PINKEYE, BOVILIS® PILIGUARD® PINKEYE+7 and BOVILIS® 20/20 VISION® 7 with SPUR® from Merck Animal Health are available to help prevent against this pathogen.
In a recent study of 466 pinkeye cases, up to 80% of cases were found to include M. bovoculi alone, or along with M. bovis1.
It Takes Two
Utilizing a combination approach to vaccination against M. bovis and M. bovoculi helps your herd gain the maximum protection they need against pinkeye.
- Protects against 8 strains of M. bovoculi in one convenient shot1
- Proven safety2
- Available on the OneMerck program
- Support from Merck Animal Health team
- Replaces autogenous products
M. bovoculi bacterin vaccine is a conditionally licensed product. To purchase, please talk to your vet or contact your Merck Animal Health sales representative.
Learn more about the complete line of pinkeye protection.
Pinkeye isn’t just a summer concern. Help producers prevent and treat pinkeye year-round.
Organisms such as Moraxella bovoculi appear to work as a co-pathogen.
No items to show.
For more cattle-friendly options, see the rest of the Merck Animal Health vaccine lineup.
1 Addison, B. June 2018. Progressive Dairy. New Findings with Bovine Pinkeye. https://www.progressivedairy.com/topics/herd-health/new-findings-with-bovinepinkeye.Accessed Feb 3, 2020.
2 USDA Summary of Studies Supporting USDA Product Licensure , January 12, 2017.